Assessment of Suppression of Cutaneous Allergic Responses and Pruritus by Topical Doxycycline
Status:
Active, not recruiting
Trial end date:
2022-05-14
Target enrollment:
Participant gender:
Summary
Investigators will study the effects of topical doxycycline on cutaneous allergic early and
late phase responses by determining allergen skin responses in each subject after a single
application to allergen induced allergic swelling of 2% doxycycline in emollient.
Phase:
Phase 2
Details
Lead Sponsor:
State University of New York - Downstate Medical Center